Biohacking Guide peptide vault logoBioHackingGuide
    CalculatorPeptide TableSourcesPeptidesJoin Email ListCommunity
    Join r/BioHackingGuideShop Peptides
    Back to Peptides
    Muscle / GH / PerformanceLongevity / Anti-Aging

    CJC-1295 DAC

    CJC-1295 with DAC (Drug Affinity Complex) is a synthetic analog of GHRH that provides sustained elevation of growth hormone and IGF-1 levels.

    Visit Trusted Source

    Mechanism of Action

    Binds to albumin for extended half-life, stimulating pulsatile GH release from the pituitary.

    Dosing Overview

    Research suggests 1-2mg once or twice weekly due to extended half-life.

    Timeline of Effects

    GH elevation begins within hours. Full benefits over 8-12 weeks of consistent use.

    Stack Suggestions

    Ipamorelin, MK-677, GHRP-6

    Safety Notes

    May cause water retention, tingling, or fatigue initially. For research purposes only.

    Reconstitution Guide

    Add 2mL bacteriostatic water to 2mg vial = 1mg/mL

    Ready to Research CJC-1295 DAC?

    Get premium quality peptides from our trusted supplier with exclusive community discounts.

    Shop Optimum Formula
    Biohacking Guide peptide vault logoBioHackingGuide

    Your peptide guide for research, dosing, and biohacking education.

    Quick Links

    Peptide Dosage CalculatorPeptide Guide TableTrusted Peptide SourcesPeptide Guides

    Community

    Biohacking Communityr/BioHackingGuide Optimum Formula

    Stay Updated

    Get the latest peptide research and guides.

    Join the email list

    Disclaimer: All information on this site is for educational and research purposes only. Peptides and research chemicals are not intended for human consumption. They are sold strictly for in-vitro research, laboratory use, or as reference standards. Always consult with qualified professionals before any research activities.

    © 2026 BioHackingGuide. All rights reserved.

    Age Verification

    This site contains research and educational content intended for adults. You must be 21 or older to continue.